Physician profile
Osman Faheem
NPI 1801073572
$2,251.87
in general payments reported to CMS, 2019-2025
10 companies · $480 in 2025
The $480 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $643 · 2020: $143 · 2021: $255 · 2022: $626 · 2024: $105 · 2025: $480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $538 · Travel and Lodging: $47.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $538.02 |
| Travel and Lodging | $47.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $555.27 | 2019-2025 | Sentinel |
| Abbott Laboratories | $350.22 | 2022-2025 | Ultreon |
| E.R. Squibb & Sons, L.L.C. | $336.32 | 2019-2020 | |
| Medtronic, INC. | $309.61 | 2024-2025 | Corevalve Evolut R |
| Edwards Lifesciences Corporation | $247.31 | 2019-2022 | |
| Atricure, INC. | $185.41 | 2022 | |
| Abiomed | $139.32 | 2022 | |
| Bardy Diagnostics, INC. | $54.14 | 2021 | |
| Novartis Pharmaceuticals Corporation | $52.25 | 2021-2022 | |
| Shockwave Medical, INC | $22.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Osman Faheem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.